2.44 USD
+0.06 (+2.52%)
2.4275 USD
-0.01 (-0.51%)
ChartMill assigns a Buy % Consensus number of 86% to CCCC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.09. This target is 395.67% above the current price.
CCCC was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CCCC.
In the previous month the buy percentage consensus was at a similar level.
CCCC was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-22 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-09-17 | Barclays | Initiate | Overweight |
| 2025-09-15 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2025-09-04 | Guggenheim | Initiate | Buy |
| 2024-12-19 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-11-18 | Stephens & Co. | Initiate | Equal-Weight |
| 2024-08-06 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-05-09 | Stifel | Maintains | Buy -> Buy |
| 2024-05-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-23 | Stifel | Reiterate | Buy -> Buy |
| 2024-01-29 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023-12-13 | Stifel | Upgrade | Hold -> Buy |
| 2023-11-06 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-11-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-09 | B of A Securities | Maintains | Neutral -> Neutral |
| 2023-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-30 | Evercore ISI Group | Maintains | Outperform |
| 2023-05-12 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-05-08 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-28 | B of A Securities | Maintains | Neutral |
| 2023-02-27 | Morgan Stanley | Maintains | Underweight |
| 2023-02-24 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | Wells Fargo | Maintains | Equal-Weight |
| 2022-11-08 | Wells Fargo | Maintains | Equal-Weight |
| 2022-11-04 | JP Morgan | Downgrade | Overweight -> Neutral |
C4 THERAPEUTICS INC / CCCC FAQ
What is the price target for CCCC stock?
13 analysts have analysed CCCC and the average price target is 12.09 USD. This implies a price increase of 395.66% is expected in the next year compared to the current price of 2.44.
Can you provide the consensus rating for C4 THERAPEUTICS INC stock?
The consensus rating for C4 THERAPEUTICS INC (CCCC) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover C4 THERAPEUTICS INC (CCCC) stock?
The number of analysts covering C4 THERAPEUTICS INC (CCCC) is 13.